Dr. Hamid Shidban, MD

Dr. Shidban practices at Keck Hospital of USC in Los Angeles, California, part of University of Southern California.

Dr. Shidban's NPI, 1942246111, was assigned on June 22, 2006. Dr. Shidban holds California license A48781.

Dr. Shidban's primary practice is Keck Hospital of USC, at 1500 San Pablo Street, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 442-8656.

Dr. Shidban's primary practice is Keck Hospital of USC in Los Angeles, California, part of University of Southern California. Dr. Shidban is also affiliated with PIH Health Good Samaritan Hospital. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Shidban to 1 more hospital, 1 physician office, 1 group practice or clinic, 1 home health agency and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shidban practices, 7 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Shidban's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Shidban is licensed in California.

CMS data shows 769 Medicare services from Dr. Shidban across 13 procedure codes in 2024, for 291 Medicare patients. Medicare paid $93,588 for them.

CMS counts 291 Medicare patients who saw Dr. Shidban in 2024. The largest group is under 65, with 178 patients. 75% of them have chronic kidney disease, and 75% have diabetes. 86% are also on Medicaid. Their average risk score is 8.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shidban's median patient age at 58, with 40% women.

In 2024, Dr. Shidban wrote 107 Medicare Part D claims for 60 patients. 95% of them were for generic drugs. CMS names the drug for 60 of them, across 2 drugs with 11 or more claims each, at $272 in total drug cost. In 2023, CMS named 117 claims across 3 drugs.

Dr. Shidban accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Shidban, published from 2010 to 2016. The most frequent topics are Glomerular Filtration Rate, Graft Rejection and Kidney Transplantation. Dr. Shidban's most frequent co-authors are Michael Abecassis, MD, Stuart M. Flechner, MD and John Judd Friedewald, MD.

CMS Open Payments shows 38 general payments to Dr. Shidban from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Veloxis Pharmaceuticals, Inc. paid the most, $741.